Use of mouse vaginal and rectal epithelium to screen antimitotic effects of systemically administered drugs.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003561:Cytarabine / Q000494:pharmacology; D004847:Epithelial Cells; D004848:Epithelium / Q000187:drug effects; D005260:Female; D005472:Fluorouracil / Q000494:pharmacology; D006918:Hydroxyurea / Q000494:pharmacology; D008466:Mechlorethamine / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D051379:Mice; D008938:Mitosis / Q000187:drug effects*; D011033:Podophyllin / Q000494:pharmacology; D012007:Rectum / Q000166:cytology* / Q000187:drug effects; D014621:Vagina / Q000166:cytology* / Q000187:drug effects; D014747:Vinblastine / Q000494:pharmacology
D000970:Antineoplastic Agents; D003561:Cytarabine; D008466:Mechlorethamine; D014747:Vinblastine; D011033:Podophyllin; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate